What is RenovoRx Inc (RNXT) stock price today?

RenovoRx Inc (RNXT) currently trades at $0.85 per share. The stock has a market capitalization of $37.84M and a P/E ratio of —x.

Is RNXT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, RenovoRx Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is RenovoRx Inc's revenue and earnings?

RenovoRx Inc has trailing twelve-month (TTM) revenue of $1.12M with profit margins of 0.00%. Earnings per share (EPS) is $-0.32.

RNXT

RenovoRx Inc

NASDAQ: RNXT · HEALTHCARE · BIOTECHNOLOGY

$0.85

+2.27% today

Updated 2026-04-30

Market cap

$37.84M

P/E ratio

—

P/S ratio

33.70x

EPS (TTM)

$-0.32

Dividend yield

—

52W range

$1 – $1

Volume

0.4M

Market cap

$37.84M

P/E ratio

—

P/S ratio

33.70x

EPS (TTM)

$-0.32

Dividend yield

—

52W range

$1 – $1

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$6.88

+709.41%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 453.50% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.02M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$43000.00	$1.12M	$1.12M
Net income	$-9.77M	$-10.23M	$-8.81M	$-11.17M	$-2.94M
EPS	—	—	—	—	$-0.32
Free cash flow	$-8.81M	$-10.26M	$-9.14M	$-10.97M	$-3.02M
Profit margin	—	—	-20,497.67%	-994.48%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RNXT	$37.84M	23	6.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

RenovoRx Inc trades at $0.85. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $1.12M.

Frequently asked questions

What is RenovoRx Inc's stock price?

RenovoRx Inc (RNXT) trades at $0.85.

Is RenovoRx Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of RenovoRx Inc (RNXT)?

The analyst target price is $6.88, representing +709.4% upside from the current price of $0.85.

What is RenovoRx Inc's revenue?

TTM revenue is $1.12M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio33.70x

ROE-225.60%

Beta1.22

50D MA$0.95

200D MA$1.03

Shares out0.05B

Float0.04B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RNXT vs LLY →RNXT vs JNJ →RNXT vs ABBV →Stock screener →